Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review. - Wikidata - awgldk - TriplyDB

Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review.

Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review.

http://www.wikidata.org/entity/Q37366279

about

Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Rever Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Prote A Review of HIV-Specific Patient-Reported Outcome Measures.Developing a patient-reported outcome measure for HIV care on perceived barriers to antiretroviral adherence: assessing the needs of HIV clinicians through qualitative analysis.Measuring quality of life among people living with HIV: a systematic review of reviews.Patient-Reported Outcome Measures in Neurosurgery: A Review of the Current Literature.

P2860

Q26799712-5EC14C8D-A35E-4716-A06C-4D20ACD696DF Q35652019-F388C90A-5BEE-4878-A5CA-F71DA5E3E867 Q35929429-72C9FE08-2616-4528-84DE-ECFC65607247 Q36073609-7411EAF3-EEA2-458C-B578-9E5E126750EC Q38956665-72F31E6D-E735-4285-BAA8-F60607103D8B Q42696743-16B2C9F2-B1DE-4C39-85F0-531571F4DE38 Q47094565-DBCA9BEE-8814-4713-8C70-3E23F1E94F23 Q49808683-BFC7822B-4543-4CC8-8750-2F0BC2BE0446

P2860

Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review.

http://www.wikidata.org/entity/Q37366279

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Patient reported outcome instr ...... sed therapy: a 10-year review.

@en

Patient reported outcome instr ...... sed therapy: a 10-year review.

@nl

type

label

Patient reported outcome instr ...... sed therapy: a 10-year review.

@en

Patient reported outcome instr ...... sed therapy: a 10-year review.

@nl

prefLabel

Patient reported outcome instr ...... sed therapy: a 10-year review.

@en

Patient reported outcome instr ...... sed therapy: a 10-year review.

@nl

P1433

Q37366279-D5BE59AA-7584-4C46-B089-89245C114AF2

P1476

Q37366279-F9B5EE7E-75E5-4826-857F-FA4AAC566CC6

P2093

Q37366279-186D13E0-23E2-499B-BB25-F0A5B6DD34BD

Q37366279-3B7867FE-0C0C-4A2B-93E1-AB09E1BFE2BA

Q37366279-A28DAB70-FEF9-4950-9FA0-AD388DA52FEE

Q37366279-A765DD37-9B7F-4206-A21C-FE259A913771

Q37366279-DA17ACE4-7A0C-4CEF-B542-660EAC090A0B

Q37366279-E0AD6A0D-5E71-4AC3-A588-A446BDF6266A

Q37366279-F54A6038-34C8-4173-8CF0-EBEDA7CC010F

Q37366279-FA259AD4-EF9E-4F8E-8857-E0B4FD3909B4

P275

Q37366279-5DB19873-0542-4861-B262-68638F19D82F

P2860

Q37366279-23B721D5-4349-4753-9753-2521D33BF058

Q37366279-2DBBD843-88A9-48C1-ABD6-EF5474B1FD2F

Q37366279-2DF7DF34-B14D-4448-AB74-7214CDCE90EC

Q37366279-2EF1F6A6-47E6-4D40-8C76-194E9BD1B8A4

Q37366279-3EC98EE9-10DB-42A4-A054-3C4DE04CA9F1

Q37366279-45BC7906-F395-4420-A4A2-FA8CC3B2160C

Q37366279-47D56DA4-DB55-4179-AA29-5EB5E06B6E97

Q37366279-48CF1ECD-FFB6-4515-A224-EF7AA562DBA9

Q37366279-5A3BAD59-C27F-4BA4-86F1-719C0934475C

Q37366279-5F66DF60-4F48-4AFD-9C9D-2ADB7F4F2093

P2888

Q37366279-5E77A397-FF68-46B3-B81A-DEFFB0E4CC2C

P304

Q37366279-42B12630-452D-407A-8168-EB8111A0C0F6

P31

Q37366279-6A7C2FBE-7440-49F0-91A1-2D077C9D476C

Q37366279-DD61CB9D-907A-4057-888D-6FF09463EB21

P356

Q37366279-216562F1-DEF9-4FC5-99AC-2656A96F0AF6

P478

Q37366279-B8CBD6C6-E474-4FBF-8B3E-89CEE626AD50

P5008

Q37366279-3323D0A5-25A9-425E-951B-0C4EDD2C8D64

P577

Q37366279-D6E2E1CF-5C45-4803-8138-4A64828606C5

P5875

Q37366279-A211B27C-B309-4D2B-9BA9-EF4C28F0DE5D

P6179

Q37366279-1075A816-9522-477C-BFEB-98C6E3E734D1

P698

Q37366279-0C51C0A1-4F0B-4F03-B767-3E564CDA6075

P921

Q37366279-2253986C-0BC4-4C2C-BF01-0786854D0098

Q37366279-61F63932-7400-41C0-A376-BA0FD6ED3AE3

Q37366279-9542E696-3F53-4BB7-9772-3C7F70564DD6

Q37366279-BED7CF34-9F95-497B-8D3A-3AEF0C74B109

Q37366279-D3784857-2144-47C1-9CD5-CE96E128FF18

Q37366279-E5FB8259-B08A-45D3-825D-2923BD6547E0

P932

Q37366279-49C07B81-E474-4D01-B21C-49FC6BAA1488

P356

1477-7525-11-164

P1433

Health and Quality of Life Outcomes

P1476

Patient reported outcome instr ...... sed therapy: a 10-year review.

@en

P2093

Albert W Wu

http://www.w3.org/2001/XMLSchema#string

Alexandra Khachatryan

http://www.w3.org/2001/XMLSchema#string

Chris L Pashos

http://www.w3.org/2001/XMLSchema#string

Gale Harding

http://www.w3.org/2001/XMLSchema#string

Kit N Simpson

http://www.w3.org/2001/XMLSchema#string

Kristin A Hanson

http://www.w3.org/2001/XMLSchema#string

Margaret Tawadrous

http://www.w3.org/2001/XMLSchema#string

Seema Haider

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.

Patient reported outcomes in routine care: advancing data capture for HIV cohort research.

Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)

Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial.

A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa

A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.

The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study.

Effects of etravirine versus placebo on health-related quality of life in treatment-experienced HIV patients as measured by the functional assessment of human immunodeficiency virus infection (FAHI) questionnaire in the DUET trials.

P2888

1477-7525-11-164

P304

164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7525-11-164

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257348179

http://www.w3.org/2001/XMLSchema#string

P6179

1034997732

http://www.w3.org/2001/XMLSchema#string

P698

24090055

http://www.w3.org/2001/XMLSchema#string

P921

Retroviridae infectious disease

mechanism of action

HIV seropositivity

biomedical investigative technique

P932

3852266

http://www.w3.org/2001/XMLSchema#string